Please ensure Javascript is enabled for purposes of website accessibility
Cytokinetics Stock Quote

Cytokinetics (NASDAQ: CYTK)

Price as of June 6, 2023, 4:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Cytokinetics Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
CYTK -4.26% +331.20% +33.95% -61%
S&P +3.94% +54.63% +9.11% +285%

Cytokinetics Company Info

Cytokinetics is a biopharmaceutical company focused on developing small-molecule therapeutics for the treatment of cardiovascular diseases and cancer.

News & Analysis


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.